These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27227989)

  • 1. miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.
    Tribollet V; Barenton B; Kroiss A; Vincent S; Zhang L; Forcet C; Cerutti C; Périan S; Allioli N; Samarut J; Vanacker JM
    PLoS One; 2016; 11(5):e0156445. PubMed ID: 27227989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
    Kroiss A; Vincent S; Decaussin-Petrucci M; Meugnier E; Viallet J; Ruffion A; Chalmel F; Samarut J; Allioli N
    Oncogene; 2015 May; 34(22):2846-55. PubMed ID: 25065599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
    Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
    PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
    Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.
    Chen Y; Zhang J; Wang H; Zhao J; Xu C; Du Y; Luo X; Zheng F; Liu R; Zhang H; Ma D
    BMC Cancer; 2012 Mar; 12():111. PubMed ID: 22439757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
    McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
    J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.
    Liu S; Guo W; Shi J; Li N; Yu X; Xue J; Fu X; Chu K; Lu C; Zhao J; Xie D; Wu M; Cheng S; Liu S
    J Hepatol; 2012 Feb; 56(2):389-96. PubMed ID: 21888875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
    Shi H; Ji Y; Zhang D; Liu Y; Fang P
    Biochem Biophys Res Commun; 2015 Sep; 465(1):125-30. PubMed ID: 26235874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.
    Zeng H; Huang Y; Liu Q; Liu H; Long T; Zhu C; Wu X
    Mol Cell Biochem; 2021 Oct; 476(10):3635-3646. PubMed ID: 34043125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
    Vargas G; Bouchet M; Bouazza L; Reboul P; Boyault C; Gervais M; Kan C; Benetollo C; Brevet M; Croset M; Mazel M; Cayrefourcq L; Geraci S; Vacher S; Pantano F; Filipits M; Driouch K; Bieche I; Gnant M; Jacot W; Aubin JE; Duterque-Coquillaud M; Alix-Panabières C; Clézardin P; Bonnelye E
    Oncogene; 2019 Feb; 38(7):950-964. PubMed ID: 30478447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway.
    Cheng Z; Liu F; Zhang H; Li X; Li Y; Li J; Liu F; Cao Y; Cao L; Li F
    Oncotarget; 2017 May; 8(19):31153-31168. PubMed ID: 28415713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
    Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J
    J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
    Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.
    Chen Y; Zhou Y; Han F; Zhao Y; Tu M; Wang Y; Huang C; Fan S; Chen P; Yao X; Guan L; Yu AM; Gonzalez FJ; Huang M; Bi H
    Theranostics; 2020; 10(16):7193-7210. PubMed ID: 32641987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.